Latest Ratios: P/E Ratio -61.7x · EV/EBITDA N/A · ROE -942.3%. (2018–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $27.1B | $7.0B | $3.3B | $5.4B | $6.4B | $18.7B | — | — | — |
| Enterprise Value | $27.1B | $7.0B | $3.2B | $5.4B | $6.4B | $18.7B | — | — | — |
| P/E Ratio → | -61.74 | — | — | — | — | — | — | — | — |
| P/S Ratio | 9999.00 | 16134.83 | 3210.86 | — | — | — | — | — | — |
| P/B Ratio | — | — | 442.23 | 1569.76 | 813.65 | 570.73 | — | — | — |
| P/FCF | — | — | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 16139.63 | 3203.24 | — | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -424.9% | -424.9% | -196.8% | — | — | — | — | — | — |
| Operating Margin | -3580.4% | -3580.4% | -2391.1% | — | — | — | — | — | — |
| Net Profit Margin | -4222.9% | -4222.9% | -2342.3% | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| ROE | -942.3% | -942.3% | -439.2% | -515.4% | -148.6% | -183.1% | — | -240.8% | -115.7% |
| ROA | -216.1% | -216.1% | -228.8% | -258.4% | -122.0% | -104.2% | -234.5% | -203.6% | -102.4% |
| ROIC | — | — | — | — | -361.6% | -228.9% | — | — | — |
| ROCE | -664.2% | -664.2% | -425.1% | -503.8% | -147.5% | -101.6% | -223.2% | -241.0% | -115.2% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | — | — | 0.03 | 0.06 | 0.05 | — | — | — | — |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | — | -1.05 | -1.71 | -1.31 | -0.54 | — | -1.07 | -1.05 |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — | — | — | — |
| Interest Coverage | -5.17 | -5.17 | — | — | -228.04 | -23.66 | -11.98 | — | — |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.57 | 0.57 | 3.02 | 1.44 | 2.34 | 10.89 | 5.95 | 5.26 | 8.58 |
| Quick Ratio | 0.37 | 0.37 | 2.42 | 1.26 | 2.34 | 10.95 | 5.95 | 5.26 | 8.58 |
| Cash Ratio | 0.32 | 0.32 | 2.29 | 1.04 | 2.16 | 10.44 | 4.92 | 5.00 | 8.58 |
| Asset Turnover | — | 0.08 | 0.09 | — | — | — | — | — | — |
| Inventory Turnover | 1.29 | 1.29 | 1.47 | 0.14 | — | — | — | — | — |
| Days Sales Outstanding | — | 90.20 | 18.74 | — | — | — | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — | — |
| Shares Outstanding | — | $841M | $60M | $46M | $33M | $33M | $32M | $32M | $32M |
Imminent liquidity and dilution
Based on reported financial data, Corvex trades at a price-to-sales multiple of 9999.00, a figure that suggests investors are pricing the company as a high-stakes call option on future intellectual property rather than a traditional hardware business with current revenue-generating capabilities or established market share.
The extreme valuation multiples reflect a complete decoupling from current operational performance, as the company lacks positive earnings or cash flow to anchor standard metrics. Investors should monitor whether this speculative premium can be sustained as the company faces the harsh reality of scaling its proprietary radiofrequency hardware in a competitive consumer market.
As reported in recent financial statements, the company's gross margin profile remains deeply negative, with a 2025Q4 margin of -21.5%, highlighting a fundamental inability to cover manufacturing costs at current, low-volume production levels for its proprietary radiofrequency hardware and associated consumer electronics components.
The persistent negative operating margins suggest that the company is currently subsidizing every unit sold, which is unsustainable without a significant shift toward economies of scale or higher-margin software services. This structural deficit warrants further investigation into whether unit economics can ever reach profitability given the high fixed costs of regulatory compliance and R&D.
According to quarterly data, the company's cash conversion cycle remains highly erratic, with a 2026Q1 figure of -175 days, which, when compared to historical trends, suggests significant volatility in inventory management and an inability to leverage supplier terms effectively during the initial commercial launch phase.
The extreme fluctuations in days inventory outstanding and days payable outstanding indicate that the company is struggling to balance its supply chain requirements with its limited cash position. This inefficiency appears to be a direct consequence of the transition from an R&D-focused entity to a commercial hardware provider, creating operational friction.
Based on the most recent quarterly filings, the company's liquidity position is precarious, with a current ratio of 0.57 as of 2025Q4, indicating a severe inability to cover short-term obligations without immediate external capital intervention or further dilutive equity financing to sustain its ongoing operations.
The rapid erosion of cash reserves suggests that the company is operating on a very thin margin of safety, making it hypersensitive to any delays in regulatory approvals or consumer demand shocks. Investors should monitor the company's ability to secure additional funding, as the current liquidity profile appears insufficient to support long-term R&D ambitions.
The most commonly misapplied metric for Corvex is the price-to-sales ratio, which obscures the company's underlying status as a cash-burning R&D entity rather than a scalable software-infrastructure firm, leading to a fundamental misunderstanding of the firm's true risk-reward profile in the competitive wearable technology sector.
Analysts should instead focus on cash burn rates and regulatory milestone progress, as these metrics provide a more accurate assessment of the company's survival probability. Relying on traditional valuation multiples for a pre-revenue or early-commercial stage medtech firm risks ignoring the significant capital requirements and execution hurdles inherent in the business model.
Includes 30+ ratios · 8 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying MOVE stock.
Corvex, Inc.'s current P/E ratio is -61.7x. This places it at the 50th percentile of its historical range.
Corvex, Inc.'s return on equity (ROE) is -942.3%. The historical average is -225.5%.
Based on historical data, Corvex, Inc. is trading at a P/E of -61.7x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Corvex, Inc. has -424.9% gross margin and -3580.4% operating margin.